Ask a Question

User wordgold11

Member for: 3 days (since Sep 19)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/Eloxatin.html
About: Combined FGFR along with Akt path inhibition abrogates increase of FGFR1 overexpressing EGFR-TKI-resistant NSCLC tissues.

Activity by wordgold11

Score: 100 points (ranked #318)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for wordgold11

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...